• ImDrug: A Deep Imbalanced Learning Benchmark for AI-Aided Drug Discovery - a conversation

  • 2024/11/24
  • 再生時間: 16 分
  • ポッドキャスト

ImDrug: A Deep Imbalanced Learning Benchmark for AI-Aided Drug Discovery - a conversation

  • サマリー

  • enjoy this great paper as a easy to understand conversation

    Summary

    The paper introduces ImDrug, a benchmark for evaluating deep imbalanced learning methods in AI-aided drug discovery. ImDrug addresses the prevalent issue of imbalanced datasets in this field, offering 11 datasets, 54 tasks, and 16 baseline algorithms. It features novel evaluation metrics (balanced accuracy and balanced F1) to mitigate biases from imbalanced data splits. The authors conduct extensive experiments across various imbalanced learning settings (classification and regression), highlighting the need for improved algorithms in this crucial area. ImDrug is open-source and provides tools for researchers to customize and expand the benchmark.

    続きを読む 一部表示

あらすじ・解説

enjoy this great paper as a easy to understand conversation

Summary

The paper introduces ImDrug, a benchmark for evaluating deep imbalanced learning methods in AI-aided drug discovery. ImDrug addresses the prevalent issue of imbalanced datasets in this field, offering 11 datasets, 54 tasks, and 16 baseline algorithms. It features novel evaluation metrics (balanced accuracy and balanced F1) to mitigate biases from imbalanced data splits. The authors conduct extensive experiments across various imbalanced learning settings (classification and regression), highlighting the need for improved algorithms in this crucial area. ImDrug is open-source and provides tools for researchers to customize and expand the benchmark.

ImDrug: A Deep Imbalanced Learning Benchmark for AI-Aided Drug Discovery - a conversationに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。